While our study is based on immunohistochemical expression analysis, these findings support the hypothesis that IDO1 and IL4I1 may cooperatively influence the tumor immune microenvironment, possibly through metabolic reprogramming and immune evasion mechanisms. Here, IDO1 is linked to neoplasm.